Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 2016; Volume 44,Issue 9

Minireview

  • You have access
    The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
    Xiaoyan Chu, Kelly Bleasby, Grace Hoyee Chan, Irene Nunes and Raymond Evers
    Drug Metabolism and Disposition September 2016, 44 (9) 1498-1509; DOI: https://doi.org/10.1124/dmd.115.067694

Articles

  • You have access
    Arylsulfatase B Mediates the Sulfonation-Transport Interplay in Human Embryonic Kidney 293 Cells Overexpressing Sulfotransferase 1A3
    Mengjing Zhao, Shuai Wang, Feng Li, Dong Dong and Baojian Wu
    Drug Metabolism and Disposition September 2016, 44 (9) 1441-1449; DOI: https://doi.org/10.1124/dmd.116.070938
  • You have access
    The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal Women
    Stefan Zajic, Stefaan Rossenu, David Hreniuk, Filippos Kesisoglou, Jacqueline McCrea, Fang Liu, Li Sun, Rose Witter, Don Gauthier, Roy Helmy, Darrick Joss, Tong Ni, Randall Stoltz, Julie Stone and S. Aubrey Stoch
    Drug Metabolism and Disposition September 2016, 44 (9) 1450-1458; DOI: https://doi.org/10.1124/dmd.116.069906
  • You have access
    Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures
    Jonathan P. Jackson, Linhou Li, Erica D. Chamberlain, Hongbing Wang and Stephen S. Ferguson
    Drug Metabolism and Disposition September 2016, 44 (9) 1463-1479; DOI: https://doi.org/10.1124/dmd.116.069831
  • CYP3A Specifically Catalyzes 1<em>β</em>-Hydroxylation of Deoxycholic Acid: Characterization and Enzymatic Synthesis of a Potential Novel Urinary Biomarker for CYP3A Activity
    You have access
    CYP3A Specifically Catalyzes 1β-Hydroxylation of Deoxycholic Acid: Characterization and Enzymatic Synthesis of a Potential Novel Urinary Biomarker for CYP3A Activity
    Martin A. Hayes, Xue-Qing Li, Gunnar Grönberg, Ulf Diczfalusy and Tommy B. Andersson
    Drug Metabolism and Disposition September 2016, 44 (9) 1480-1489; DOI: https://doi.org/10.1124/dmd.116.070805
  • You have access
    Evaluation of Clopidogrel Conjugation Metabolism: PK Studies in Man and Mice of Clopidogrel Acyl Glucuronide
    Simona Nicoleta Savu, Luigi Silvestro, Mariana Surmeian, Lina Remis, Yuksel Rasit, Simona Rizea Savu and Constantin Mircioiu
    Drug Metabolism and Disposition September 2016, 44 (9) 1490-1497; DOI: https://doi.org/10.1124/dmd.116.071092
  • You have access
    Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur
    Yanwei Li, Xing Kang, Ge Yang, Penggao Dai, Chao Chen and Huijuan Wang
    Drug Metabolism and Disposition September 2016, 44 (9) 1510-1515; DOI: https://doi.org/10.1124/dmd.115.069153
  • Open Access
    Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates
    Donglu Zhang, Shang-Fan Yu, Yong Ma, Keyang Xu, Peter S. Dragovich, Thomas H. Pillow, Luna Liu, Geoffrey Del Rosario, Jintang He, Zhonghua Pei, Jack D. Sadowsky, Hans K. Erickson, Cornelis E. C. A. Hop and S. Cyrus Khojasteh
    Drug Metabolism and Disposition September 2016, 44 (9) 1517-1523; DOI: https://doi.org/10.1124/dmd.116.070631
  • You have access
    Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters
    Edwin C. Y. Chow, Jason Z. Y. Wang, Holly P. Quach, Hui Tang, David C. Evans, Albert P. Li, Jose Silva and K. Sandy Pang
    Drug Metabolism and Disposition September 2016, 44 (9) 1524-1535; DOI: https://doi.org/10.1124/dmd.116.070060
  • You have access
    Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects
    Eyas Raddad, Amy Chappell, Jeffery Meyer, Alan Wilson, Charles E. Ruegg, Johannes Tauscher, Michael A. Statnick, Vanessa Barth, Xin Zhang and Steven J. Verfaille
    Drug Metabolism and Disposition September 2016, 44 (9) 1536-1542; DOI: https://doi.org/10.1124/dmd.116.070359

Errata

  • You have access
    Correction to “Variability in Expression of CYP3A5 in Human Fetal Liver”
    Drug Metabolism and Disposition September 2016, 44 (9) 1459; DOI: https://doi.org/10.1124/dmd.115.064998err
  • You have access
    Correction to “A Recombinant Humanized Anti-Cocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Rats”
    Drug Metabolism and Disposition September 2016, 44 (9) 1460-1462; DOI: https://doi.org/10.1124/dmd.114.057034err
  • You have access
    Correction to: Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics
    Drug Metabolism and Disposition September 2016, 44 (9) 1516; DOI: https://doi.org/10.1124/dmd.115.071753err
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 44 (9)
Drug Metabolism and Disposition
Vol. 44, Issue 9
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics